학술논문
Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-years*
Document Type
Article
Author
Source
In: Journal of Market Access and Health Policy . (Journal of Market Access and Health Policy, 2017, 5(1))
Subject
Language
English
ISSN
20016689